🚀 VC round data is live in beta, check it out!
MicroPort EP Valuation Multiples
Discover revenue and EBITDA valuation multiples for MicroPort EP and similar public comparables like Wandong Medical, Immunocore Holdings, UFP Technologies, 4DMedical and more.
MicroPort EP Overview
About MicroPort EP
Shanghai MicroPort EP Medtech Co Ltd is engaged in the research and development, production and sales of various medical devices and equipment related to cardiac electrophysiology interventional diagnosis and treatment.
Founded
2010
HQ
Employees
N/A
Website
Financials (LTM)
EV
$1B
MicroPort EP Financials
MicroPort EP reported last 12-month revenue of $70M and EBITDA of $9M.
In the same LTM period, MicroPort EP generated $41M in gross profit, $9M in EBITDA, and $8M in net income.
Revenue (LTM)
MicroPort EP P&L
In the most recent fiscal year, MicroPort EP reported revenue of $67M and EBITDA of $13M.
MicroPort EP expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $70M | XXX | $67M | XXX | XXX | XXX |
| Gross Profit | $41M | XXX | $39M | XXX | XXX | XXX |
| Gross Margin | 58% | XXX | 58% | XXX | XXX | XXX |
| EBITDA | $9M | XXX | $13M | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | 19% | XXX | XXX | XXX |
| EBIT Margin | 12% | XXX | 11% | XXX | XXX | XXX |
| Net Profit | $8M | XXX | $7M | XXX | XXX | XXX |
| Net Margin | 12% | XXX | 11% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
MicroPort EP Stock Performance
MicroPort EP has current market cap of $2B, and enterprise value of $1B.
Market Cap Evolution
MicroPort EP's stock price is $3.39.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $2B | -0.2% | XXX | XXX | XXX | $0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMicroPort EP Valuation Multiples
MicroPort EP trades at 20.2x EV/Revenue multiple, and 152.3x EV/EBITDA.
EV / Revenue (LTM)
MicroPort EP Financial Valuation Multiples
As of April 5, 2026, MicroPort EP has market cap of $2B and EV of $1B.
Equity research analysts estimate MicroPort EP's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
MicroPort EP has a P/E ratio of 193.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | 20.2x | XXX | 20.9x | XXX | XXX | XXX |
| EV/EBITDA | 152.3x | XXX | 110.4x | XXX | XXX | XXX |
| EV/EBIT | 163.7x | XXX | 182.2x | XXX | XXX | XXX |
| EV/Gross Profit | 34.6x | XXX | 36.1x | XXX | XXX | XXX |
| P/E | 193.3x | XXX | 215.3x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (310.0x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified MicroPort EP Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
MicroPort EP Margins & Growth Rates
MicroPort EP's revenue in the last 12 month grew by 18%.
MicroPort EP's rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
MicroPort EP's rule of X is 52% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
MicroPort EP Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 18% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | 37% | XXX | (13%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 29% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 52% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 10% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 10% | XXX | 9% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 14% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 50% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
MicroPort EP Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Wandong Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Immunocore Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| UFP Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| 4DMedical | XXX | XXX | XXX | XXX | XXX | XXX |
| AtriCure | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MicroPort EP M&A Activity
MicroPort EP acquired XXX companies to date.
Last acquisition by MicroPort EP was on XXXXXXXX, XXXXX. MicroPort EP acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by MicroPort EP
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMicroPort EP Investment Activity
MicroPort EP invested in XXX companies to date.
MicroPort EP made its latest investment on XXXXXXXX, XXXXX. MicroPort EP invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by MicroPort EP
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout MicroPort EP
| When was MicroPort EP founded? | MicroPort EP was founded in 2010. |
| Where is MicroPort EP headquartered? | MicroPort EP is headquartered in China. |
| Is MicroPort EP publicly listed? | Yes, MicroPort EP is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of MicroPort EP? | MicroPort EP trades under 688351 ticker. |
| When did MicroPort EP go public? | MicroPort EP went public in 2022. |
| Who are competitors of MicroPort EP? | MicroPort EP main competitors are Wandong Medical, Immunocore Holdings, UFP Technologies, 4DMedical. |
| What is the current market cap of MicroPort EP? | MicroPort EP's current market cap is $2B. |
| What is the current revenue of MicroPort EP? | MicroPort EP's last 12 months revenue is $70M. |
| What is the current revenue growth of MicroPort EP? | MicroPort EP revenue growth (NTM/LTM) is 18%. |
| What is the current EV/Revenue multiple of MicroPort EP? | Current revenue multiple of MicroPort EP is 20.2x. |
| Is MicroPort EP profitable? | Yes, MicroPort EP is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of MicroPort EP? | MicroPort EP's last 12 months EBITDA is $9M. |
| What is MicroPort EP's EBITDA margin? | MicroPort EP's last 12 months EBITDA margin is 13%. |
| What is the current EV/EBITDA multiple of MicroPort EP? | Current EBITDA multiple of MicroPort EP is 152.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.